Liabilities and Equity of Burning Rock Biotech Ltd from 31 Dec 2019 to 31 Dec 2024

Taxonomy & unit
us-gaap: USD and CNY
Description
Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.
Summary
Burning Rock Biotech Ltd quarterly Liabilities and Equity in USD history and change rate from 31 Dec 2019 to 31 Dec 2024.
  • Burning Rock Biotech Ltd Liabilities and Equity for the quarter ending 31 Dec 2024 was $121,288,000, a 17% decline year-over-year.
Burning Rock Biotech Ltd quarterly Liabilities and Equity in CNY history and change rate from 31 Dec 2019 to 31 Dec 2024.
  • Burning Rock Biotech Ltd Liabilities and Equity for the quarter ending 31 Dec 2024 was ¥885,305,000, a 15% decline year-over-year.
Source SEC data
View on sec.gov
Liabilities and Equity, Quarterly (USD)
Liabilities and Equity, YoY Quarterly Change (%)
Liabilities and Equity, Quarterly (CNY)
Liabilities and Equity, YoY Quarterly Change (%)

Burning Rock Biotech Ltd Quarterly Liabilities and Equity (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2024 $121,288,000 -$25,194,000 -17% 31 Dec 2024 20-F 29 Apr 2025 2024 FY
Q4 2023 $146,482,000 -$83,680,000 -36% 31 Dec 2023 20-F 29 Apr 2024 2023 FY
Q4 2022 $230,162,000 -$127,400,000 -36% 31 Dec 2022 20-F 20 Apr 2023 2022 FY
Q2 2022 $277,882,000 30 Jun 2022 6-K 07 Nov 2022 2022 Q2
Q4 2021 $357,562,000 -$50,567,000 -12% 31 Dec 2021 20-F 29 Apr 2022 2021 FY
Q4 2020 $408,129,000 31 Dec 2020 20-F 23 Mar 2021 2020 FY

Burning Rock Biotech Ltd Quarterly Liabilities and Equity (CNY)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2024 ¥885,305,000 -¥154,696,000 -15% 31 Dec 2024 20-F 29 Apr 2025 2024 FY
Q4 2023 ¥1,040,001,000 -¥547,466,000 -34% 31 Dec 2023 20-F 29 Apr 2025 2024 FY
Q4 2022 ¥1,587,467,000 -¥691,120,000 -30% 31 Dec 2022 20-F 29 Apr 2024 2023 FY
Q2 2022 ¥1,861,274,000 30 Jun 2022 6-K 07 Nov 2022 2022 Q2
Q4 2021 ¥2,278,587,000 -¥384,441,000 -14% 31 Dec 2021 20-F 20 Apr 2023 2022 FY
Q4 2020 ¥2,663,028,000 +¥1,815,471,000 +214% 31 Dec 2020 20-F 29 Apr 2022 2021 FY
Q4 2019 ¥847,557,000 31 Dec 2019 20-F 23 Mar 2021 2020 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.